Literature DB >> 27302552

Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat.

Emel Aygören-Pürsün1, Markus Magerl2, Jochen Graff3, Inmaculada Martinez-Saguer4, Wolfhart Kreuz4, Hilary Longhurst5, Iman Nasr5, Murat Bas6, Ulrich Straßen6, Lei Fang7, Melanie Cornpropst8, Sylvia Dobo8, Phil Collis8, William P Sheridan8, Marcus Maurer9.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27302552     DOI: 10.1016/j.jaci.2016.03.043

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors.

Authors:  Zhe Li; James Partridge; Abel Silva-Garcia; Peter Rademacher; Andreas Betz; Qing Xu; Hing Sham; Yunjin Hu; Yuqing Shan; Bin Liu; Ying Zhang; Haijuan Shi; Qiong Xu; Xubo Ma; Li Zhang
Journal:  ACS Med Chem Lett       Date:  2016-12-06       Impact factor: 4.345

Review 2.  Pediatric Angioedema.

Authors:  Debendra Pattanaik; Jay Adam Lieberman
Journal:  Curr Allergy Asthma Rep       Date:  2017-08-08       Impact factor: 4.806

Review 3.  Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.

Authors:  Henriette Farkas
Journal:  Paediatr Drugs       Date:  2018-04       Impact factor: 3.022

4.  A score for the differential diagnosis of bradykinin- and histamine-induced head and neck swellings.

Authors:  M Lenschow; M Bas; F Johnson; M Wirth; U Strassen
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-02       Impact factor: 2.503

Review 5.  Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Marcus Maurer; Kilian Eyerich; Stefanie Eyerich; Marta Ferrer; Jan Gutermuth; Karin Hartmann; Thilo Jakob; Alexander Kapp; Pavel Kolkhir; Désirée Larenas-Linnemann; Hae-Sim Park; Gunnar Pejler; Mario Sánchez-Borges; Knut Schäkel; Dagmar Simon; Hans-Uwe Simon; Karsten Weller; Torsten Zuberbier; Martin Metz
Journal:  Int Arch Allergy Immunol       Date:  2020-03-30       Impact factor: 2.749

6.  The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.

Authors:  Marcus Maurer; Markus Magerl; Stephen Betschel; Werner Aberer; Ignacio J Ansotegui; Emel Aygören-Pürsün; Aleena Banerji; Noémi-Anna Bara; Isabelle Boccon-Gibod; Konrad Bork; Laurence Bouillet; Henrik Balle Boysen; Nicholas Brodszki; Paula J Busse; Anette Bygum; Teresa Caballero; Mauro Cancian; Anthony J Castaldo; Danny M Cohn; Dorottya Csuka; Henriette Farkas; Mark Gompels; Richard Gower; Anete S Grumach; Guillermo Guidos-Fogelbach; Michihiro Hide; Hye-Ryun Kang; Allen P Kaplan; Constance H Katelaris; Sorena Kiani-Alikhan; Wei-Te Lei; Richard F Lockey; Hilary Longhurst; William Lumry; Andrew MacGinnitie; Alejandro Malbran; Inmaculada Martinez Saguer; Juan José Matta Campos; Alexander Nast; Dinh Nguyen; Sandra A Nieto-Martinez; Ruby Pawankar; Jonathan Peter; Grzegorz Porebski; Nieves Prior; Avner Reshef; Marc Riedl; Bruce Ritchie; Farrukh Rafique Sheikh; William B Smith; Peter J Spaeth; Marcin Stobiecki; Elias Toubi; Lilian Agnes Varga; Karsten Weller; Andrea Zanichelli; Yuxiang Zhi; Bruce Zuraw; Timothy Craig
Journal:  World Allergy Organ J       Date:  2022-04-07       Impact factor: 5.516

7.  Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study.

Authors:  M A Riedl; E Aygören-Pürsün; J Baker; H Farkas; J Anderson; J A Bernstein; L Bouillet; P Busse; M Manning; M Magerl; M Gompels; A P Huissoon; H Longhurst; W Lumry; B Ritchie; R Shapiro; D Soteres; A Banerji; M Cancian; D T Johnston; T J Craig; D Launay; H H Li; M Liebhaber; T Nickel; J Offenberger; W Rae; R Schrijvers; M Triggiani; H J Wedner; S Dobo; M Cornpropst; D Clemons; L Fang; P Collis; W P Sheridan; M Maurer
Journal:  Allergy       Date:  2018-06-17       Impact factor: 13.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.